118 related articles for article (PubMed ID: 19525474)
1. Molecular imaging of monocrotaline-induced pulmonary vascular disease with radiolabeled linear adrenomedullin.
Dupuis J; Harel F; Fu Y; Nguyen QT; Letourneau M; Préfontaine A; Fournier A
J Nucl Med; 2009 Jul; 50(7):1110-5. PubMed ID: 19525474
[TBL] [Abstract][Full Text] [Related]
2. PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension.
Merabet N; Nsaibia MJ; Nguyen QT; Shi YF; Letourneau M; Fournier A; Tardif JC; Harel F; Dupuis J
Sci Rep; 2019 Apr; 9(1):6609. PubMed ID: 31036871
[TBL] [Abstract][Full Text] [Related]
3. PulmoBind, an adrenomedullin-based molecular lung imaging tool.
Létourneau M; Nguyen QT; Harel F; Fournier A; Dupuis J
J Nucl Med; 2013 Oct; 54(10):1789-96. PubMed ID: 23949911
[TBL] [Abstract][Full Text] [Related]
4. SPECT imaging of pulmonary vascular disease in bleomycin-induced lung fibrosis using a vascular endothelium tracer.
Harel F; Nguyen QT; Nsaibia MJ; Finnerty V; Morgan A; Sirois M; Villeneuve L; Calderone A; Bergeron A; Brochiero E; Tardif JC; Shi Y; Dupuis J
Respir Res; 2021 Sep; 22(1):240. PubMed ID: 34481508
[TBL] [Abstract][Full Text] [Related]
5. Use of adrenomedullin derivatives for molecular imaging of pulmonary circulation.
Harel F; Fu Y; Nguyen QT; Letourneau M; Perrault LP; Caron A; Fournier A; Dupuis J
J Nucl Med; 2008 Nov; 49(11):1869-74. PubMed ID: 18927321
[TBL] [Abstract][Full Text] [Related]
6. Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor.
Blankenberg FG; Mandl S; Cao YA; O'Connell-Rodwell C; Contag C; Mari C; Gaynutdinov TI; Vanderheyden JL; Backer MV; Backer JM
J Nucl Med; 2004 Aug; 45(8):1373-80. PubMed ID: 15299064
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution, plasma kinetics and quantification of single-pass pulmonary clearance of adrenomedullin.
Dupuis J; Caron A; Ruël N
Clin Sci (Lond); 2005 Jul; 109(1):97-102. PubMed ID: 15740458
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal in vivo SPECT/CT imaging reveals morphological changes and cardiopulmonary apoptosis in a rodent model of pulmonary arterial hypertension.
Paffett ML; Hesterman J; Candelaria G; Lucas S; Anderson T; Irwin D; Hoppin J; Norenberg J; Campen MJ
PLoS One; 2012; 7(7):e40910. PubMed ID: 22815866
[TBL] [Abstract][Full Text] [Related]
9. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline.
Yoshihara F; Nishikimi T; Horio T; Yutani C; Takishita S; Matsuo H; Ohe T; Kangawa K
Eur J Pharmacol; 1998 Aug; 355(1):33-9. PubMed ID: 9754936
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid-X-receptor expression in monocrotaline-induced pulmonary arterial hypertension and right heart failure.
Ye L; Jiang Y; Zuo X
Biochem Biophys Res Commun; 2015 Nov; 467(1):164-70. PubMed ID: 26392308
[TBL] [Abstract][Full Text] [Related]
11. CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway.
Zhang TT; Cui B; Dai DZ; Su W
Acta Pharmacol Sin; 2005 Nov; 26(11):1309-16. PubMed ID: 16225752
[TBL] [Abstract][Full Text] [Related]
12. Augmented adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertension.
Shimokubo T; Sakata J; Kitamura K; Kangawa K; Matsuo H; Eto T
Life Sci; 1995; 57(19):1771-9. PubMed ID: 7475919
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats.
Samnick S; Scheuer C; Münks S; El-Gibaly AM; Menger MD; Kirsch CM
Nucl Med Biol; 2004 May; 31(4):511-22. PubMed ID: 15093822
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection.
Rennen HJ; Boerman OC; Oyen WJ; Corstens FH
J Nucl Med; 2003 Sep; 44(9):1502-9. PubMed ID: 12960199
[TBL] [Abstract][Full Text] [Related]
15. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
Zhao L; Ashek A; Wang L; Fang W; Dabral S; Dubois O; Cupitt J; Pullamsetti SS; Cotroneo E; Jones H; Tomasi G; Nguyen QD; Aboagye EO; El-Bahrawy MA; Barnes G; Howard LS; Gibbs JS; Gsell W; He JG; Wilkins MR
Circulation; 2013 Sep; 128(11):1214-24. PubMed ID: 23900048
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging.
Fu Y; Létourneau M; Nguyen QT; Chatenet D; Dupuis J; Fournier A
Eur J Pharmacol; 2009 Sep; 617(1-3):118-23. PubMed ID: 19559019
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of FGFR Signaling With PD173074 Ameliorates Monocrotaline-induced Pulmonary Arterial Hypertension and Rescues BMPR-II Expression.
Zheng Y; Ma H; Hu E; Huang Z; Cheng X; Xiong C
J Cardiovasc Pharmacol; 2015 Nov; 66(5):504-14. PubMed ID: 26535780
[TBL] [Abstract][Full Text] [Related]
20. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
